Patricia R. Freeman
University of Kentucky
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Patricia R. Freeman.
The Economic Journal | 2008
Karen Blumenschein; Glenn C. Blomquist; Magnus Johannesson; Nancy Horn; Patricia R. Freeman
Concern exists that hypothetical willingness to pay questions overestimate real willingness to pay. In a field experiment, we compare two methods of removing hypothetical bias, a cheap talk approach and a certainty approach, with real purchases. We find evidence of hypothetical bias for unadulterated contingent valuation. Contingent valuation with certainty statements removes the hypothetical bias, but the cheap talk approach has no significant impact. Our findings suggest that willingness to pay can be accurately estimated by adding a simple follow-up question about the certainty of responses and that cheap talk is not a generally effective approach.
Journal of Health Economics | 2001
Karen Blumenschein; Magnus Johannesson; Krista K Yokoyama; Patricia R. Freeman
Abstract We conducted a field experiment comparing hypothetical and real purchase decisions for a pharmacist provided asthma management program among 172 subjects with asthma. Subjects received either a dichotomous choice contingent valuation question or were given the opportunity to actually enroll in the program. Three different prices were used: US
PharmacoEconomics | 2002
Alan J. Zillich; Karen Blumenschein; Magnus Johannesson; Patricia R. Freeman
15, 40, and 80. In the hypothetical group, 38% of subjects said that they would purchase the good at the stated price, but only 12% of subjects in the real group purchased the good ( p =0.000). We cannot, however, reject the null hypothesis that “definitely sure” hypothetical yes responses, as identified in a follow-up question, correspond to real yes responses. We conclude that the dichotomous choice contingent valuation method overestimates willingness to pay, but that it may be possible to correct for this overestimation by sorting out “definitely sure” yes responses.
Journal of The American Pharmacists Association | 2011
Molly B. Carr; Holly Divine; Cathy Hanna; Patricia R. Freeman; Karen Blumenschein
AbstractObjective: The primary objective was to evaluate the relationship between willingness-to-pay (WTP), quality-of-life (QOL), and disease-severity measures in patients with asthma. The hypothesis studied was that patients with asthma with more severe disease are willing to pay more for a hypothetical cure of asthma than those with less severe disease.n Design setting/Patients and participants: One hundred patients with asthma were recruited from community pharmacies in Kentucky for 30-minute face-to-face interviews.n Interventions: Spirometry assessed objective disease severity in terms of pulmonary function, while a multiple choice question measured subjective disease severity. The Medical Outcomes Study 36-item Short Form (SF-36) health survey and Asthma Technology of Patient Experience (Asthma TyPE) measured quality of life. WTP was obtained via a dichotomous choice contingent valuation question.n Results: In this exploratory evaluation, WTP was significantly related to both objective disease severity (p = 0.02) and subjectively assessed disease severity (p = 0.01). For objective disease severity the mean monthly WTP was
Journal of The American Pharmacists Association | 2014
Katelyn M. Alexander; Holly Divine; Cathy Hanna; Yevgeniya Gokun; Patricia R. Freeman
US90 for mild asthma,
Journal of The American Pharmacists Association | 2017
Patricia R. Freeman; Amie Goodin; SuZanne Troske; Audra Strahl; Amanda Fallin; Traci C. Green
US131 for moderate asthma and
Journal of The American Pharmacists Association | 2017
Emma Palmer; Steve Hart; Patricia R. Freeman
US331 for severe asthma and for subjective disease severity the mean monthly WTP was
JAMA | 2012
Jeffery C. Talbert; Karen Blumenschein; Amy Burke; Arnold Stromberg; Patricia R. Freeman
US48 for mild asthma,
Drug and Alcohol Dependence | 2018
N.J. Pauly; Svetla Slavova; Chris Delcher; Patricia R. Freeman; Jeffery C. Talbert
US166 for moderate asthma and
Journal of Rural Health | 2018
Huong Luu; Svetla Slavova; Patricia R. Freeman; Michelle R. Lofwall; Steven R. Browning; Heather M. Bush
US241 for severe asthma.n Conclusions: The results suggest that the WTP for a cure from asthma is related to both objective and subjective disease severity. These findings contribute to the case for construct validity of the dichotomous choice contingent valuation method in the healthcare sector.